Uganda, at high risk for Ebola, starts vaccinating medics

Compartir

Uganda will begin vaccinating frontline health workers against Ebola next week as the threat increases of the deadly virus spreading from neighboring Democratic Republic of Congo, the health minister said Friday. "There's really a need for some sort of intervention to protect those workers".

This precaution is being taken because the health care officials are anxious that the infection would spread into the country from the borders shared with Democratic Republic of Congo. Ebola broke out in Eastern DRC province in August this year and it has since killed about 200 people according to World Health Organization report and it reportedly continues to spread to areas close to Uganda.

As the North Kivu province Ebola outbreak enters its fourth month, worldwide health officials are worrying if the combination of violence and insecurity in the area will render this outbreak past the point of control. The individuals in DRC who have been in contact with an Ebola patient have been vaccinated and those in contact with these contacts have also been vaccinated.

La calificadora Fitch baja a negativa su nota sobre la deuda argentina
En tanto, la inflación cerraría 2018 en 47 por ciento y se desaceleraría a un 27,5 por ciento en 2019, de acuerdo a sus estimaciones.

The strategy in Uganda involves an experimental vaccine, which officials say will not be given to the public. "Scientists believe such invaluable lives would have been saved had a vaccine been in existence then".

Besides militia attacks that have hindered health workers, the region's high population density and movements across the borders to Uganda and Rwanda pose additional risks that the highly lethal fever disease could spread in the region. The conflict slows healthcare workers' attempts to fight the virus. An outbreak in the western part of the country was declared over in July, after infecting 53 people and killing 33.Just days later, the current outbreak was discovered across the vast Central African nation, in a region that has been at the heart of multiple conflicts.Maggie FoxMaggie Fox is senior writer for NBC News and TODAY, writing top news and analysis on health policy, science, medical treatments and disease. The infection killed 11,000 died in Sierra Leone, Liberia and Guinea and infected 28,000 in the period between 2014 and 2016. There are some experimental antibody based therapies that are being tried in treating the disease.

This latest vaccine to be administered has been developed by Merck and is not yet licensed.

Compartir